Eli Lilly Fights Back: Medical Spas and Online Sellers in Crosshairs Over Knockoff Weight-Loss Drugs
Eli Lilly has launched legal action against three online vendors and medical spas, accusing them of peddling unapproved versions of its blockbuster weight-loss drug, Zepbound. The pharmaceutical giant claims these entities—Pivotal Peptides, MangoRx, and Genesis Lifestyle Medicine—are misusing the drug’s core ingredient, tirzepatide, to market copycat treatments, including dissolvable tablets and unauthorized compounded versions. This …